You are here

Consultation on Extemporaneous Compounding of Emergency Medicines

8 December 2021

Opening date: 7 December 2021

Closing date: 7 February 2022

The Therapeutic Goods Administration (TGA) sought feedback on a proposal to improve patient access to critical medicines in acute-care settings.

Timely access to critical medicines is essential for medical professionals and their patients, particularly in acute-care settings.

We sought your feedback on proposed regulatory reforms to support hospital pharmacists to extemporaneously compound certain medicines in advance of a patient being identified, so they can be available for immediate use in an emergency.

For more information and to have your say, please view the consultation paper and complete the online survey on the TGA Consultation Hub.

The public consultation opened on 7 December 2021 and closed on 7 February 2022.


If you have questions relating to this consultation or how to submit your feedback please email